Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Salmeterol

Generic name
Salmeterol
Brand name
ATC Code
R03AC12

Pharmacokinetics in children

No information

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Available formulations

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Dosages

Bronchial dilation (long-acting)
  • Inhalation
    • Aerosol
      • 4 years up to 18 years
        • 50 - 100 microg./day in 2 doses. in combination with inhalation corticosteroids..
        • Do not use as a treatment for attacks.

          Administration: dosing aerosol with a holding chamber with a mouthpiece.

    • Inhalation powder
      • 7 years up to 18 years
        • 50 - 100 microg./day in 2 doses. in combination with inhalation corticosteroids.
        • Do not use as a treatment for attacks.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Renal impaiment in children > 3 months

GFR ≥10 ml/min/1.73m2: Dose adjustment not required.

GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

There is insufficient data known about the use of salmeterol in children aged under 4 years. Before prescribing salmeterol, a bronchodilating response should be confirmed and documented by making an FEV1 measurement before and after beta-2 mimetics. An alternative to the lung function measurements in children aged less than 6 years is a good clinical response to a short-acting beta-2-agonist. Use of long-acting beta-2-agonist should be prescribed in the secondary care sector as per the guidelines of the NHG (Dutch College of General Practitioners) and the SKL (Paediatric Pulmonary Disease Section).
Do not use as treatment for acute asthma attacks.
Administration: Serevent dosing aerosol can be administered in combination with the following holding chambers: Volumatic (age > 4 years)

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

References

  1. NVK sectie Kinderlongziekten, Medicamenteuze behandeling van astma bij kinderen. Herziene richtlijnen van kinderlongartsen, 2007
  2. GlaxoSmithKline BV, SPC Serevent aerosol (RVG 33735), www.cbg-meb.nl, Geraadpleegd 27 oktober 2010, http://db.cbg-meb.nl/IB-teksten/h33735.pdf

A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.

Changes

Changes